Membrane signaling by complement C5b-9, the membrane attack complex |
| |
Authors: | Anne Nicholson-Weller MD Jose A. Halperin |
| |
Affiliation: | 1. Department of Medicine, Brigham and Women's Hospital, Boston, Mass., USA 2. Department of Cellular and Molecular Physiology, Harvard Medical School, Boston, Mass., USA 3. Charles A. Dana Research Institute, Harvard Thorndike Laboratories, Beth Israel Hospital, Harvard Medical School, Boston, Mass., USA 4. Department of Medicine, Beth Israel Hospital, Harvard Medical School, Boston, Mass., USA 5. Division of Infections Disease, Beth Israel Hospital, 330 Brookline Avenue, DA-617, 02215, Boston, Mass., (USA)
|
| |
Abstract: | The terminal complement complexes C5b-7, C5b-8 and C5b-9 are able to generate nonlethal cell signals. One universal consequence of a cell being targeted by C5b-8 or C5b-9 is an influx of Ca2+. In addition, other second messengers, including cAMP, inositol phosphate intermediates and arachidonate metabolites, are generated by the terminal complement complexes in specific cell types. In vivo, terminal complement complexes have been found in a wide variety of inflammatory processes in humans and in experimental animal models. Some of these models of inflammation putatively induced by terminal complement complexes have been tested in complement-deficient animals, and indeed no inflammation results, which supports the critical role of the terminal complement complexes in the pathogenesis of the lesion. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|